<?xml version="1.0" encoding="UTF-8"?>
<ref id="B42-vaccines-08-00115">
 <label>42.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Donofrio</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Sartori</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Ravanetti</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Cavirani</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Gillet</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Vanderplasschen</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Taddei</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Flammini</surname>
    <given-names>C.F.</given-names>
   </name>
  </person-group>
  <article-title>Establishment of a bovine herpesvirus 4 based vector expressing a secreted form of the bovine viral diarrhoea virus structural glycoprotein E2 for immunization purposes</article-title>
  <source>BMC Biotechnol.</source>
  <year>2007</year>
  <volume>7</volume>
  <elocation-id>68</elocation-id>
  <pub-id pub-id-type="doi">10.1186/1472-6750-7-68</pub-id>
  <?supplied-pmid 17945009?>
  <pub-id pub-id-type="pmid">17945009</pub-id>
 </element-citation>
</ref>
